Borderline Resectable Pancreatic Ductal Adenocarcinoma
specificA pancreatic ductal adenocarcinoma term that refers to a continuum between resectable and locally advanced unresectable disease.
3
Centers
4
Active Trials
—
Cancer Funding
Top Centers for Borderline Resectable Pancreatic Ductal Adenocarcinoma(3)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive High-Volume Research Center | 81.7 |
| 2 | OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive Active Research Program | 59.2 |
| 3 | BC CancerVancouver, BC Active Research Program | 59.2 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →